Loading...

BMEA BIOMEA FUSION INC Management Changes 8-K Filing

BM F

BM

BIOMEA FUSION INC

(BMEA)

2025 8-K

Show Summary

Summary

Equity Offerings

Equity Offerings

Product Expansion

Financial Statements

Financial Results

Management Changes

Management Change

Clinical Trial Results

Preclinical Data Update

Financial Results

FDA Approval Update

Earnings Reports

Annual Meeting Voting Results

Other Special Situation

Earnings Reports

Earnings Reports

Presentation of Patient Coh...

Presentation at J.P. Morgan...

Earnings Reports

Earnings Reports

Product Updates

Earnings Reports

Earnings Reports

Underwriting Agreement

Clinical Trial Data Announc...

Financial Results Announcement

Press Release and Presentation

External Links:

Biomea Fusion Inc. reported on March 27, 2025, that it is not compliant with Nasdaq's audit committee requirements due to a resignation, and it plans to regain compliance by appointing a new member before March 25, 2026. Additionally, Thomas Butler resigned as CEO on March 25, 2025, and Dr. Hitchcock was appointed as interim CEO with a salary of $633,000 and a stock option grant.

AI Assistant

BIOMEA FUSION INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.